(Q44365787)

2 December 2017

title

Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies (English)

1 reference

2 December 2017

main subject

phase I clinical trial

0 references

1 reference

1 reference

2

David R Gandara

1 reference

2 December 2017

Edith A Perez

1

1 reference

2 December 2017

Martin J Edelman

3

1 reference

2 December 2017

Robert O'Donnell

4

1 reference

2 December 2017

Ignacio J Lauder

5

1 reference

2 December 2017

Michael DeGregorio

6

1 reference

2 December 2017

language of work or name

1 reference

1 January 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

21

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

1-6

1 reference

Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

The molecular basis of cisplatin sensitivity/resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Signaling and drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Targeting chemosensitizing doses of toremifene based on protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Tamoxifen modulation of cisplatin cytotoxicity in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Enhancement of the antiproliferative effect ofcis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

A phase I trial of high-dose oral tamoxifen and CHOPE

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016397

21 January 2018

Identifiers

DOI

10.1081/CNV-120016397

1 reference

release_cigcpxuchfgghi3ff4mjewfjaq

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cigcpxuchfgghi3ff4mjewfjaq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference